BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10984892)

  • 1. [Quantification in bone scintigraphy with Tc-99m-phosphonates: determinants and data points].
    Büll U; Reinartz P
    Nuklearmedizin; 2000 Aug; 39(5):N69-71. PubMed ID: 10984892
    [No Abstract]   [Full Text] [Related]  

  • 2. New vistas on bone scintigraphy.
    Nucl Med Commun; 1984 Jun; 5(6):359-60. PubMed ID: 6241663
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic and imaging evaluation of (99m)Tc-HBIDP as a potential bone imaging agent.
    Qiu L; Lin J; Nan B; Lv G; Cheng W
    Pak J Pharm Sci; 2015 May; 28(3):815-8. PubMed ID: 26004712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies on the detection of bone metastasis in lung cancer by bone scintigraphy].
    Nakano S; Hasegawa Y; Kajita A; Nakamura S; Horai T; Ikegami H; Matuda M; Okamoto N; Nabeshima H; Doi O; Komatubara Y; Ishigami S
    Kaku Igaku; 1983 Feb; 20(1):37-43. PubMed ID: 6308314
    [No Abstract]   [Full Text] [Related]  

  • 5. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphosphonates in the evaluation of metabolic bone disease.
    Fogelman I; Smith ML
    Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reaction of 99mTc-diphosphonate with N-donor ligands.
    Johannsen B
    Int J Appl Radiat Isot; 1982 Jun; 33(6):429-32. PubMed ID: 6286510
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
    Weber DA; Makler PT; Watson EE; Coffey JL; Thomas SR; London J
    J Nucl Med; 1989 Jun; 30(6):1117-22. PubMed ID: 2544697
    [No Abstract]   [Full Text] [Related]  

  • 10. What do we want from a bone-scanning agent?
    Fogelman I; Bessent RG
    J Nucl Med; 1980 Mar; 21(3):296. PubMed ID: 6445001
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparation and in vivo biological investigations on a novel radioligand for bone scanning: technetium-99m-labeled zoledronic acid derivative.
    Lin J; Qiu L; Cheng W; Luo S; Ye W
    Nucl Med Biol; 2011 Jul; 38(5):619-29. PubMed ID: 21718936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios.
    Buell U; Kirsch CM; Kleinhans E; Jäger B
    J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
    Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
    Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bone scan as a tumour marker in prostatic carcinoma.
    Chisholm GD; Stone AR; Beynon LL; Merrick MV
    Eur Urol; 1982; 8(5):257-60. PubMed ID: 6288389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
    Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
    J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
    Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
    J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat.
    Watt I; Hill P
    Br J Radiol; 1981 Jul; 54(643):592-6. PubMed ID: 6455174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical value of bone and gallium scintigraphy for soft-tissue sarcomas of the extremities.
    Kirchner PT; Simon MA
    J Bone Joint Surg Am; 1984 Mar; 66(3):319-27. PubMed ID: 6230363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruptured abdominal aortic aneurysm identified incidental to bone scintigraphy.
    Moreno AJ; Brown JM; Spicer MJ; Brown TJ
    Eur J Nucl Med; 1983; 8(12):546-8. PubMed ID: 6230233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.